CDMO News
Agilent Expands CDMO Services with BIOVECTRA Acquisition
Agilent Technologies Inc. has announced a definitive agreement to acquire BIOVECTRA, a specialized contract development and manufacturing organization (CDMO), for $925 million. The acquisition aims to enhance Agilent’s capabilities in biologics, highly potent active pharmaceutical ingredients, and other targeted therapeutics. BIOVECTRA, based
23 July 2024
Stay ahead of trends and best practices
